Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling

Shu Zhang1, Xiaoning Zeng, Haiwei Yang

  • 1Clinical Research Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Abstract

Insights

Mast cell tryptase activates brain microglia, releasing inflammatory factors via the PAR-2-MAPK-NF-kappa B pathway. This finding sheds light on microglia-mediated brain inflammation.

Area of Science:

  • Neuroimmunology
  • Cellular and Molecular Neuroscience

Background:

  • Mast cell tryptase is known to activate peripheral immune cells, contributing to inflammation.
  • The role of tryptase in activating microglia, the brain's resident immune cells, was previously uninvestigated.
  • Microglia are crucial for central nervous system (CNS) immune surveillance.

Purpose of the Study:

  • To investigate the effect of mast cell tryptase on microglia activation.
  • To elucidate the signaling pathways involved in tryptase-induced microglia activation.

Main Methods:

  • Primary microglia cultures were used to examine tryptase-induced activation.
  • Pro-inflammatory factors (TNF-alpha, IL-6), reactive oxygen species (ROS), and mitochondrial membrane potential were measured.
  • MAPK and NF-kappa B phosphorylation were assessed via Western blot.

Main Results:

  • Tryptase stimulated microglia activation, leading to the release of TNF-alpha, IL-6, and ROS.
  • Protease-activated receptor-2 (PAR-2) activation was involved in tryptase-induced inflammatory mediator release and mitochondrial dysfunction.
  • Tryptase-induced microglia activation was mediated by ERK and p38 MAPK pathways and NF-kappa B activation via PAR-2.

Conclusions:

  • Tryptase induces microglia activation and pro-inflammatory mediator release through the PAR-2-MAPK-NF-kappa B signaling pathway.
  • This mechanism contributes to the development of microglia-mediated inflammation in the brain.
  • Targeting this pathway may offer therapeutic strategies for neuroinflammatory conditions.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Inflammation01:38

Inflammation

Overview
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...